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Biology and Genetics, Dresden, GermanyABSTRACT Microtubule diversity, arising from the utilization of different tubulin genes and from posttranslational modifi-
cations, regulates many cellular processes including cell division, neuronal differentiation and growth, and centriole assem-
bly. In the case of cilia and flagella, multiple cell biological studies show that microtubule diversity is important for axonemal
assembly and motility. However, it is not known whether microtubule diversity directly influences the activity of the axonemal
dyneins, the motors that drive the beating of the axoneme, nor whether the effects on motility are indirect, perhaps through
regulatory pathways upstream of the motors, such as the central pair, radial spokes, or dynein regulatory complex. To test
whether microtubule diversity can directly regulate the activity of axonemal dyneins, we asked whether in vitro acetylation or
deacetylation of lysine 40 (K40), a major posttranslational modification of a-tubulin, or whether proteolytic cleavage of the
C-terminal tail (CTT) of a- and b-tubulin, the location of detyrosination, polyglutamylation, and polyglycylation modifications
as well as most of the genetic diversity, can influence the activity of outer arm axonemal dynein in motility assays using
purified proteins. By quantifying the motility with displacement-weighted velocity analysis and mathematically modeling
the results, we found that K40 acetylation increases and CTTs decrease axonemal dynein motility. These results show
that axonemal dynein directly deciphers the tubulin code, which has important implications for eukaryotic ciliary beat
regulation.INTRODUCTIONThe tubulin code hypothesis proposes that microtubule di-
versity differentially regulates molecular motors and micro-
tubule associated proteins (1). Microtubule diversity arises
through the expression of multiple tubulin isotypes, which
differ primarily in their C-terminal tails (CTTs) (2), and
through multiple posttranslational modifications (PTMs)
(2–4). These include acetylation of a-tubulin’s lysine 40
(K40) on the luminal surface of the microtubule and
modifications to the a- and b-tubulin CTTs (2) on the outer
surface of the microtubule. However, the molecular mecha-
nisms by which the tubulin code regulates cellular processes
are only just beginning to be understood.
There is cell biological and genetic evidence that tubulin
PTMs regulate the activity of molecular motors in the cyto-
plasm. For example, K40 acetylation marks stable micro-
tubules, which preferentially recruit cytoplasmic dynein
and kinesin-1, and increases the speed of kinesin-1 (5–7);
this is thought to play an important role in neuronal polari-
zation (8) and integrity (5,9). To test whether motors can
directly sense tubulin modifications, the recent identifica-
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0006-3495/14/12/2872/9 $2.00(aTAT) (10,11) and SIRT2 (12), has facilitated biochemical
studies. In the case of K40 acetylation, no effect on the
motility of kinesin-1 was found using purified proteins
(13,14), suggesting that regulation of kinesin-1 motility by
acetylation may be indirect. On the other hand, in vitro as-
says show that CTTs and their associated PTMs can regulate
a variety of cytoplasmic motors (15), extending earlier
studies showing that enzymatic removal of the CTTs can
influence the processivity and microtubule binding rate
of kinesin-1, kinesin-13, and cytoplasmic dynein (16–19).
Thus, there is evidence that PTMs can directly regulate
cytoplasmic motor motility.
Cilia and flagella are motile and sensory organelles
containing an axoneme, a microtubule-based structure.
Axonemal microtubules are distinguished from cytoplasmic
microtubules through the differential expression of tubulin
isotypes and prominent PTMs (4), suggesting that microtu-
bule diversity may play a role in ciliary function. Indeed,
K40 acetylation defects slightly reduce the swimming speed
of Chlamydomonas cells (20) and cause abnormal mouse
sperm function (21), though no swimming defects are
seen in Tetrahymena cells (22). Defects in polyglutamyla-
tion, the addition of glutamic acid side chains to CTTs
(23), slow Tetrahymena (24) and Chlamydomonas (25,26)
swimming and reduce mouse brain ependymal cilia beat
frequency (27). Antibodies against the CTT sequences of
b-I, b-IV, and b-V tubulin, which are cilia and flagella spe-
cific isotypes (2), but not against other tubulin sequences,
inhibit the beating of bovine cilia (28). Because these effectshttp://dx.doi.org/10.1016/j.bpj.2014.10.061
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(21,22,25), it is possible that the tubulin code regulates
axonemal dynein, the motor protein that is directly respon-
sible for ciliary motility. However, to our knowledge, there
is no direct, in vitro evidence of axonemal dynein regulation
through tubulin diversity. In this study, we present biochem-
ical and biophysical evidence that axonemal dynein can read
the tubulin code.MATERIALS AND METHODS
Cells and media
As described in previous works (29,30), the Chlamydomonas reinhardtii
strain used was oda2-t-lc2-bccp (31), which lacks the g HC outer arm
axonemal dynein motor and has a light-chain 2 biotin-carboxyl-carrier
protein (lc2-bccp) construct to bind the a and b HC outer arm axonemal
dynein complexes to a streptavidin-coated substrate in a site-specific
manner (31). Outer arm axonemal dyneins were used in these studies
because their activity has been associated with establishing ciliary beat fre-
quency (32), and PTM mutants often have beat frequency phenotypes
(25,27). The cells were grown in liquid Tris-acetate-phosphate (TAP) me-
dium (20 mM Tris, 7 mM NH4Cl, 0.40 mM MgSO4, 0.34 mM CaCl2,
2.5 mM PO3
-4, and 1000-fold diluted Hutner’s trace elements (33), titrated
to pH 7.0 with glacial acetic acid) with continuous aeration and 24 h of light
at room temperature. 60 L of cell culture were grown to a density of 5 to
10  106 cells/mL.Axonemal dynein purification
As described in previous work (29,30), the oda2-t-lc2-bccp cells were
harvested and the axonemes were isolated by standard methods (34).
Briefly, cells were harvested by centrifugation and deciliated with
dibucaine (Sigma-Aldrich, St. Louis, MO). The cilia were isolated and
diluted into HMDE (30 mM HEPES, 5 mM MgSO4, 1 mM DTT, and
1 mM EGTA, titrated to pH 7.4 with potassium hydroxide (KOH))
with 0.4 mM Pefabloc (Sigma-Aldrich). They were demembranated
with IGEPAL CA-630 (Sigma-Aldrich) and washed in HMDE. The
axonemal dyneins were extracted with 0.6 M KCl and purified using a
MonoQ 10/100 GL (GE Healthcare, Piscataway, NJ) ion-exchange col-
umn (35). The axonemal dyneins were eluted with a linear gradient of
150 to 400 mM KCl in HMDE and stored at 300 mg/mL in 30% saturated
sucrose at -80C.Tubulin purification and labeling
Porcine brain tubulin was purified by standard methods (36). Briefly,
porcine brains were homogenized and clarified by centrifugation. Active
tubulin in the supernatant was purified with polymerization and depolymer-
ization cycles. Tubulin was separated from the microtubule-associated pro-
teins with a phosphocellulose column (P11, Whatman, Piscataway, NJ).
Porcine brain tubulin was labeled with 5 (and 6)-carboxytetramethylrhod-
amine, succinimidyl ester (TAMRA, SE; Invitrogen, Life Technologies,
Darmstadt, Germany) by incubating the dye with polymerized microtu-
bules. The active labeled tubulin was obtained with additional polymeriza-
tion and depolymerization cycles.
Axonemal tubulin from Chlamydomonas was purified as previously
described (29,30). Briefly, the microtubules in the axoneme pellet obtained
after axonemal dynein extraction were induced to depolymerize with
50 mM CaCl2 and incubation in an ice-cold sonicating bath. This crude
tubulin extract applied to a TOG1/2 domain column (37), and eluted with
KCl.Microtubule preparation
Rhodamine-labeled porcine brain microtubules were polymerized from 2 to
8 mM tubulin, 30% rhodamine-labeled and 70% unlabeled, in BRB80
(80 mM PIPES, 1 mM MgCl2, and 1 mM EGTA, titrated to pH 6.9 with
KOH) with 1 mM Guanosine-50-[(a,b)-methyleno]triphosphate (GMPCPP,
Jena Bioscience, Jena, Germany), and 1 mM MgCl2, for 2 h at 37
C. They
were stabilized by diluting them in BRB80 with 20 mM taxol (paclitaxel,
Sigma-Aldrich).
Chlamydomonas microtubules were polymerized from 8 mM tubulin
in BRB80 with 4 mM MgCl2, 1 mM GTP, and 4% DMSO for 30 min
at 37C. They were stabilized by diluting them in BRB80 with 20 mM taxol.In vitro acetylation and deacetylation
To acetylate microtubules in vitro (13), 20 mM 30% rhodamine-labeled
porcine microtubules were incubated with 3 mM aTAT (recombinantly ex-
pressed and purified murine aTAT, which is also known as MEC-17 (10),
was a generous gift fromWilhelmWalter and Stefan Diez, B CUBE–Center
for Molecular Bioengineering, TU Dresden, Dresden, Germany) and
120 mM acetyl-coenzyme A (acetyl-CoA, Sigma-Aldrich) in 60 mM Tris-
HCl, pH 8.0 for the indicated times at 28C.
To deacetylate microtubules in vitro, Chlamydomonas tubulin at 17 mM
was incubated with 50 mg/mL human recombinant His-Tag SIRT2 (EMD
Millipore, Darmstadt, Germany), 0.5 mM NADþ (Sigma Aldrich) in
40 mM PIPES with 0.5 mM DTT, 0.8 mM EGTA, and 0.5 mM MgSO4
at pH 7.0 at room temperature for 2 h. This deacetylated tubulin was further
polymerized into microtubules as described above.
The controls for both cases were treated in the same manner, just without
addition of aTATor SIRT2. The microtubules were used for gliding assays,
SDS-PAGE, and Western blots.CTT cleavage
Forty mM microtubules were incubated with 10 mg/mL or 200 mg/mL sub-
tilisin A (Sigma-Aldrich) in BRB80 with 20 mM taxol at 30C for 1 h. The
reaction was quenched by addition of 4 mM phenylmethylsulfonyl fluoride
(Thermo Scientific). The s-tubulin microtubules were separated from the
cleaved CTTs and the buffer was exchanged to BRB80 with 20 mM taxol
by centrifugation in an Airfuge Air-Driven Ultracentrifuge (Beckman
Coulter, Brea, CA). The controls were treated in the same manner, just
without the addition of subtilisin A.SDS-PAGE, Western blots, and antibodies
SDS-PAGE was done using 4-12% Bis-Tris gels (NuPAGE, Life Tech-
nologies, Darmstadt, Germany) or 4%–15% Mini-PROTEAN TGX
Stain-Free Gels (BioRad, Hercules, CA). Proteins were visualized with
Coomassie brilliant blue (Life Technologies) or by following the manufac-
turers instructions for visualizing stain-free gels using the ChemiDoc MP
gel imaging system (BioRad). Proteins were transferred to nitrocellulose
membranes with an iBlot (Life Technologies) or a TurboBlot (BioRad).
Primary antibodies were used to detect particular tubulin motifs: K40
acetylation was detected with anti-K40 acetylated a-tubulin (6-11B-1,
Sigma-Aldrich); polyglutamylation was detected with antipolyglutamy-
lated tubulin (GT335, AdipoGen, San Diego, CA); detyrosination was de-
tected with antidetyrosinated tubulin (AB3201, EMD-Millipore); D2
tubulin was detected with anti-D2 tubulin (D2, EMD-Millipore); a-tubulin
CTTs were detected with anti-a-tubulin YL1/2 (MAB1864, EMD-Milli-
pore); b-tubulin CTTs were detected with anti-b-III tubulin (TU-20, Santa
Cruz Biotechnology, Dallas, TX); non-CTT epitopes of a-tubulin were
detected with anti-a-tubulin (DM1-a, Sigma-Aldrich); and non-CTT
epitopes of b-tubulin were detected with anti-b-tubulin (TU-06, EXBIO,
Vestec, Czech Republic). Appropriate alkaline-phosphatase conjugatedBiophysical Journal 107(12) 2872–2880
2874 Alper et al.secondary antibodies (goat, mouse, or rabbit; Sigma-Aldrich and Life Tech-
nologies) were used with NBT/BCIP (WesternBreeze Chromogenic Kit
from Life Technologies, or AMRESCO, Solon, OH) for subsequent chro-
mogenic detection. Developed Western blots were imaged with an Epson
Perfection V700 Photo scanner and quantified with ImageJ.Microtubule gliding assays
As described in previous work (29,30), microtubule gliding assays were
performed in 5 mL flow channels made from an 18  18 mm cover
slip (Corning B.V. Life Sciences, Amsterdam, Netherlands) spaced
~100 mm from a 20  20 mm cover slip (Corning) or microscope slide
(Corning) by Parafilm M (Pechiney Plastic Packaging, Chicago, IL). The
flow channels were filled sequentially with the following solutions:
20 mL HMDE; 10 mL 1 mg/mL biotinylated bovine serum albumin
(BSA); 20 mL HMDE; 10 mL 1 mg/mL streptavidin; 20 mL HMDE;
10 mL 5 mg/mL BSA; 20 mL HMDE; 10 mL 100 mg/mL axonemal dynein;
20 mL HMDEwith 1 mMADP; 10 mL microtubule solution (0.5 mMmicro-
tubules, 20 mM taxol, and 1 mMADP in HMDE); 20 mL HMDEwith 1 mM
ADP and 20 mM taxol; and 10 mL motility solution (1 mMATP, 1 mMADP,
20 mM taxol, 4 mg/mL catalase, 10 mg/mL glucose oxidase, 20 mM
D-glucose, and 1% b-mercaptoethanol in HMDE). Note that solutions sub-
sequently imaged in dark field were centrifuged in an Airfuge before use
and the catalase, glucose oxidase and D-glucose were omitted from the
motility solution. All solutions containing protein were incubated in the
flow channel for 5 min.
Rhodamine-labeled porcine microtubules were imaged translocating
using a Zeiss Axiovert 200M microscope with a Zeiss 100/1.46 a-Plan-
Apochromat Oil Ph3, Plan-NeoFlaur 40/1.3, or Plan ApoChromat 63/
1.4 Ph water objective at 23C. Alternatively, unlabeled Chlamydomonas
microtubules were imaged using a Plan-NeoFluar 100/1.3 objective
with iris and a Zeiss dark field oil condenser/1.3. Images were acquired
with a Metamorph (Molecular Devices, Sunnyvale, CA) or Andor iQ (An-
dor TechTology, Belfast, UK) software-driven Andor DV887 iXon camera.
The exposure time was 100 ms, and 2000 frame movies were recorded
continuously.
In each movie, microtubules were tracked with 50 nm precision, and the
displacement along the microtubule’s path and the microtubule’s length
were calculated in every frame using Fluorescence Image Evaluation Soft-
ware for Tracking and Analysis (FIESTA) (38). The instantaneous velocity
of the microtubule was calculated over 0.4 s intervals after smoothing the
data with a third-degree Savitzky-Golay filter with a span of nine data
points (29,30). The displacement-weighted mean velocities were calculated
as described in Alper et al. 2013 (29) by binning the instantaneous veloc-
ities in 200 nm/s bins. Displacement-weighted mean velocity data plotted
against microtubule length were weighted by the total tracked displacement
and fitted to the Mechaelis-Menten-like equation (Eq. 1) using the Leven-
berg-Marquardt method of calculating a nonlinear least squares regression
in MATLAB (The MathWorks, Natick, MA).
All gliding assay data were collected using microtubules from at least
two enzymatic treatments, each in at least two flow channels, and from
one to three movies from each flow channel. The reported data were pooled
based on the lack of statistical significance of any differences between
movies from the same experimental conditions.RESULTS
To determine whether axonemal dyneins sense tubulin
modifications, we studied two classes of modifications:
a-tubulin K40 acetylation and those localized to the CTTs.
We treated microtubules in vitro to alter the state of either
of these groups, andwe tested the effect on purified axonemal
dynein in reconstituted in vitro motility assays.Biophysical Journal 107(12) 2872–2880aTAT treatment acetylates porcine microtubules
We incubated porcine-brain microtubules with recombinant
mouse aTAT (10,11), which transfers the acetyl group
from acetyl-CoA to the epsilon amine of a-tubulin K40
(Fig. 1 A). Using an antiacetylated-K40 antibody (39), we
found that aTAT-treated microtubules were more heavily
acetylated than untreated microtubules (Fig. 1 B). aTAT
treatment did not affect polyglutamylation, detyrosination,
or D2 generation, which is the irreversible cleavage of the
C-terminal glutamic acid and tyrosine from a-tubulin (2)
(Fig. 1 B).Increased aTAT incubation time increases the
amount of porcine tubulin that is acetylated
To determine the effect of porcine microtubule K40 acety-
lation on axonemal dynein motility, we generated increas-
ingly acetylated microtubules by treating microtubules
with aTAT for increasing periods. We found that the amount
of acetylation increased with increasing aTAT exposure
time (Fig. 1 C). We quantified the Western blot by densitom-
etry and found that acetylation saturated to a level ~15-fold
over untreated microtubules after 60 min of aTAT treatment
(Fig. 1 D).Acetylation increases the speed of axonemal
dynein on porcine brain microtubules
We performed in vitro gliding assays using the increasingly
acetylated porcine brain microtubules to determine if
acetylation affects the motility of axonemal outer arm
axonemal dynein purified from Chlamydomonas. Using
fluorescence microscopy, we recorded movies of the rhoda-
mine-labeled porcine microtubules gliding on axonemal
dynein-coated slides and tracked each microtubule’s path
in the movies. Because the gliding motility was unsteady,
as is typical for axonemal dyneins (see Fig. 1 E for a
typical example) (29,31,40), we calculated the mean veloc-
ity of each microtubule track using displacement-weighted
velocity analysis (29). We plotted the displacement-
weighted mean velocity (v) against the microtubule length
(L) for each condition (see Fig. 1 F for an example condi-
tion) and fit these data with the following Michaelis-
Menten-like equation (29,40) using nonlinear regression
(see Materials and Methods):
vðLÞ ¼ vmax L
L0 þ L; (1)
where vmax is the displacement-weighted mean velocity
reached in the limit of long microtubules (Fig. 1 F), and
L0 is the length of the microtubule with gliding velocity
vmax/2 (Fig. 1 F). The fit curve was not significantly
different from the data (c2 ¼ 12.0, df ¼ 9, p ¼ 0.21).
We tested an extension of Eq. 1 by adding a constant.
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FIGURE 1 Increasing acetylation increases axonemal dynein speed on
porcine microtubules. (A) Schematic of tubulin acetylation and deacety-
lation by aTAT and SIRT2, respectively. The orange and red circles
represent a- and b-tubulins, respectively. The yellow circle represents
the acetylated form of K40. (B) Western blots of porcine microtubules
treated with aTAT showing that aTAT treatment significantly increased
the fraction of acetylated tubulin whereas the CTT-associated PTMs
were unaffected. Tubulin loading was assayed by visualization in the
gel using the TGX Stain-Free Precast Gel protocol before transfer to
the nitrocellulose membrane. (C) Western blot of microtubules treated
with aTAT showing that increased aTAT treatment time increases the
fraction of acetylated tubulin. (D) Densitometry of the Western blot
from panel C. (E) Example raw gliding assay data. (top) Typical kymo-
graph of a microtubule (length ¼ 2.6 mm) gliding on axonemal dynein
The Tubulin Code Regulates Dynein 2875We found that the value of the constant was not signifi-
cantly different from zero (Student’s t-test, t ¼ 0.33,
df ¼ 7, p ¼ 0.82), indicating that adding a constant does
not increase the goodness of fit. When we added coopera-
tivity by raising all lengths to the power n (Hill coeffi-
cient), we found that n was not significantly different
from one (Student’s t-test, t ¼ 0.094, df ¼ 7, p ¼ 0.93).
This indicates that Eq. 1 provides a simple and satisfactory
fit to the data. By contrast, a linear fit was significantly
different from the data (c2 ¼ 25.5, df ¼ 9, p ¼ 0.0024).
We found that vmax increased with increasing aTAT acet-
ylation time and that the effect on velocity saturated after
30 min of aTAT acetylation time to a value that was about
threefold higher than untreated microtubules (Fig. 1 G). L0
also increased with acetylation time (Fig. 1 H), but a linear
regression indicated that this increase was not statistically
significant (slope ¼ 0.0059 5 0.0032 mm/min, fit param-
eter 5 SE of the fit, t ¼ 1.84, df ¼ 6, p ¼ 0.12). We
will discuss the implications of the increase in vmax and
the lack of a statistically significant change in L0 on the
motility properties of molecular axonemal dynein in the
Discussion section.SIRT2 treatment deacetylates Chlamydomonas
axonemal tubulin
To further investigate the effects of acetylation on the
motility of axonemal dynein, we deacetylated purified Chla-
mydomonas axonemal tubulin, which is strongly K40-acet-
ylated in vivo (39,41), using recombinant human SIRT2 to
remove the acetyl group from K40 (Fig. 1 A) (12). We found
that SIRT2-treated tubulin was much less acetylated than
untreated tubulin (Fig. 2 A). Additionally, we confirmed
that SIRT2 treatment did not affect the polyglutamylation,
detyrosination, or D2 generation of Chlamydomonas tubulin
(Fig. 2 A).that shows the characteristic unsteadiness of axonemal dynein gliding
assays. (bottom) Plot of the microtubule’s distance traveled as a function
of time. This is an example of typical gliding data after tracking. (F)
Typical plot of mean microtubule gliding velocity as a function of micro-
tubule length. This example is for the case of untreated microtubules.
The data points were calculated by pooling microtubules in 2 mm bins
and averaging their displacement-weighted mean velocities. The error
bars are the standard error of the mean for each bin. The line is a least
squares fit to Eq. 1 calculated before pooling and weighted by total dis-
tance traveled. This fit was used to calculate vmax and L0, shown with
dashed lines, and it is typical of all cases. (G) The calculated vmax for
each aTAT treatment condition plotted as a function of acetylation
time. (H) The calculated L0 for each aTAT treatment condition plotted
as a function of acetylation time. The data points for panels G and H
were calculated by pooling the microtubule tracks from at least three
movies per condition. A total of 213, 140, 280, 257, 1034, 94, 474,
and 438 microtubules were analyzed for the aTAT treatment times of
0, 1, 2, 5, 10, 20, 30, and 90 min, respectively. The error bars in G
and H are the standard errors for each parameter. To see this figure in
color, go online.
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AB
FIGURE 2 Deacetylation decreased axonemal dynein speed on Chlamy-
domonas microtubules. (A) Western blots of Chlamydomonas microtubules
treated with SIRT2 showing that SIPT2 treatment significantly decreased
the fraction of acetylated tubulin whereas other CTT-associated PTMs
were unaffected. Tubulin loading was assayed by visualization in the gel us-
ing the TGX Stain-Free Precast Gel protocol before transfer to the nitrocel-
lulose membrane. (B) The mean velocity of SIRT2-treated (triangles) and
untreated (circles) microtubules plotted as a function of microtubule length.
The data points were calculated by pooling microtubules in 1 mm bins and
averaging their displacement-weighted velocities. The error bars are the
standard error of the mean for each microtubule bin. The lines, which are
least-squares fits to Eq. 1 for the unpooled SIRT2-treated (dashed) and un-
treated (solid) microtubules, respectively, were calculated before pooling
and weighted by total distance traveled.
2876 Alper et al.Deacetylation decreases the speed of axonemal
dynein on Chlamydomonas microtubules
We performed in vitro gliding assays to determine if de-
acetylation of Chlamydomonas microtubules affects the
motility of axonemal dynein. Using dark field microscopy
to record movies of gliding unlabeled Chlamydomonas mi-
crotubules and by fitting the tracked data to Eq. 1, we found
that deacetylation decreased the vmax by 20%, from 2.095
0.06 mm/s for untreated microtubules to 1.665 0.06 mm/s
for SIRT2-treated microtubules (vmax5 SE of the fit, N ¼
613 and 538 microtubule tracks, respectively). Though the
effect was subtle, the decrease in velocity was statistically
significant (p < 0.001, Student’s t-test, see Fig. 2 B).
We found that deacetylation slightly decreased L0, from
0.43 5 0.08 mm for untreated microtubules to 0.39 5
0.08 mm for SIRT2-treated microtubules (L0 5 SE
of the fit, N ¼ 613 and 538 microtubule tracks, respec-
tively, Fig. 2 B), but not significantly so (p > 0.5, Student’s
t-test).
There is no statistical significance in the differences be-
tween deacetylated and control microtubules with L >
5 mm (Fig. 2 B, two-sample t-tests, for the 5.5 mm data
point: t¼ 0.14, df ¼ 29, p¼ 0.89; for the 6.5 mm data point:Biophysical Journal 107(12) 2872–2880t ¼ 0.38, df ¼ 14, p ¼ 0.71); however, this is because of the
small number of tracked microtubules of these lengths.
t-tests on the deacetylated data points for L > 5 mm show
that these data points are not statistically different from
the fit line (for the 5.5 mm data point: t ¼ 1.85, df ¼ 6,
p ¼ 0.11; for the 6.5 mm data point: t ¼ 0.68, df ¼ 5, p ¼
0.53). Therefore, despite the lack of difference between
the deacetylated and control microtubules with L > 5 um,
there is strong, statistically significant evidence that long
deacetylated microtubules are slower than control ones,
because, when all the data is included in the fit, vmax is
significantly lower for deacetylated microtubules than for
control ones.Subtilisin cleaves off the C-terminal tails and the
removes CTT-related posttranslational
modifications from porcine microtubules
To test the effects of the C-terminal tails and CTT-related
PTMs on axonemal dynein’s motility, we removed the
2-4 kDa CTTs, including the associated posttranslational
modifications, from porcine microtubules in vitro using
the subtilisin A protease (Fig. 3 A). Because a- and
b-tubulin CTTs are differently susceptible to subtilisin
treatment (19), we treated polymerized microtubules
with 200 mg/mL, 10 mg/mL, and 0 mg/mL (as a control)
of subtilisin. We found that digestion by 10 mg/mL of
subtilisin increased the mobility of one tubulin in SDS-
PAGE: one of the Coomassie brilliant blue-stained bands
migrated farther, with lower apparent molecular weight,
than the other (Fig. 3 B, compare lane 2 with lane 1).
Neither anti-a-tubulin-CTTs nor anti-b-tubulin-CTTs
stained the altered band in Western blots. Only anti-
a-tubulin-CTTs stained the unchanged band (Fig. 3 B).
We conclude that the 10 mg/mL subtilisin digestion
cleaved the CTTs off b-tubulin leaving a- bs-tubulin
microtubules, where bs-tubulin indicates the s-tubulin
form of b-tubulin. Digestion with 200 mg/mL yielded the
appearance of a second higher-mobility band and the
disappearance of the lower-mobility band (Fig. 3 B, lane
3). Neither of the bands in lane 3 were stained by anti-
a-tubulin-CTTs or anti-b-tubulin-CTTs in Western blots
(Fig. 3 B). This indicated that the 200 mg/mL subtilisin
digestion cleaved the CTTs off both a- and b-tubulin leav-
ing as- bs-tubulin microtubules. The 200 mg/mL subtilisin
digestion left no detectable CTTs on a- or b-tubulin in the
microtubules (Fig. 3 B).
We confirmed that subtilisin treatment removed
CTT-related posttranslational modifications with several
antibodies. Polyglutamylation, detyrosination, and D2
generation were eliminated from b-tubulin with 10 mg/
mL and from both a- and b-tubulin with 200 mg/mL
subtilisin treatments (Fig. 3 C). However, the anti-K40
acetylated tubulin antibody stained the control and both
treatments (Fig. 3 C).
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FIGURE 3 CTT cleavage increases axonemal dynein speed on
porcine microtubules. (A) Schematic of CTT cleavage by subtilisin.
The orange and red circles represent a- and b-tubulins, respectively.
The orange and red branched lines represent a- and b-tubulin CTTs
with their CTT-related PTMs, respectively. (B) Gel electrophoresis of
subtilisin-treated porcine microtubules stained with Coomassie brilliant
blue. The bands are identified with arrows. a-tubulin and b-tubulin
CTTs were visualized in these Western blots with CTT-specific anti-
bodies. (C) Western blots of porcine microtubules treated with subtilisin
showing that CTT-related posttranslational modifications were cleaved
by treatment, whereas K40 acetylation remained in all treatments. a-
and b-tubulins were visualized with antibodies that recognize epitopes
not in their CTTs. (D) The calculated vmax for axonemal dynein on
a- b-tubulin microtubules (0 mg/mL), a- bs-tubulin microtubules
(10 mg/mL), and as- bs-tubulin microtubules (200 mg/mL). (E) The
calculated L0 for each subtilisin treatment. The data reported in both
D and E were the fit parameters from a nonlinear least squares regres-
sion of 392, 711, and 712 microtubule tracks from subtilisin incubation
concentrations of 200, 10, and 0 mg/mL, respectively. The error bars are
the standard errors of the regression for each parameter. To see this
figure in color, go online.
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axonemal dynein
We performed in vitro gliding assays to determine how
CTTs, and the posttranslational modifications that localize
to CTTs, affect the motility of axonemal dynein. We
analyzed the motility as we had done for acetylated micro-
tubules above. We found that cleavage of b-tubulin CTTs
from porcine microtubules increased vmax by ~15%, from
1.70 5 0.05 mm/s for untreated microtubules to 1.93 5
0.05 mm/s for 10 mg/mL subtilisin-treated microtubules
(vmax5 SE of the fit, N ¼ 712 and 711 microtubule tracks,
respectively, Fig. 3 D). Cleavage of both a- and b-tubulin
CTTs with the 200 mg/mL subtilisin treatment increased
vmax by ~35%, from 1.705 0.05 mm/s for untreated micro-
tubules to 2.27 5 0.07 mm/s for 200 mg/mL subtilisin-
treated microtubules (vmax 5 SE of the fit, N ¼ 712 and
392 microtubule tracks, respectively, Fig. 3 D). The values
of vmax were significantly different from each other and
from untreated microtubules (p < 0.001 in all cases, Stu-
dent’s t-test). We found that CTTs did not have a significant
effect on L0 (Fig. 3 E, p > 0.5 in both cases, Student’s
t-test).DISCUSSION
Acetylation regulates the motility of outer arm
axonemal dynein
We found that the speed of Chlamydomonas outer arm
axonemal dynein on mammalian microtubules increased
up to threefold after acetylation with aTAT (Fig. 1 G).
Thus, the reduced motility of sperm in aTAT knockout
mice (21) may be because of a direct effect on axonemal
dynein. We also found a small effect on the motility of
axonemal dynein on Chlamydomonas microtubules de-
acetylated by SIRT2 consistent with the small reduc-
tion of swimming speed in Chlamydomonas cells with
reduced acetylation (20). Therefore, our results support
the hypothesis that acetylation regulates the ciliary beat
through a direct modulation of axonemal dynein-microtu-
bule interactions.
Our results have interesting implications regarding in-
side-out signaling across the microtubule wall. K40 is
located on the inner, luminal surface of the microtubule
(42,43), yet its acetylation regulates the motility of the
axoneme, which ultimately involves the interactions be-
tween axonemal dynein and the outer surface of the micro-
tubule. Likewise, microtubule-inner proteins, MIPs, are also
implicated in the regulation of the ciliary beat (44). These
findings suggest that there is a communication pathway
through the microtubule wall in cilia. However, there is
scant biochemical evidence for a direct effect of acetylation
on motility. Reed et al. found that intact axonemes from a
Tetrahymena mutant that lacks K40 acetylation (a-tubulin
K40R) are moved more slowly by kinesin-1 than axonemesBiophysical Journal 107(12) 2872–2880
2878 Alper et al.from wildtype cells (7) despite the a-tubulin K40R mutation
leading to no significant difference in Tetrahymena swim-
ming velocity (22). It is possible that the effect is indirect.
For example, the lack of acetylation may disrupt microtu-
bule assembly within the axoneme leading to structural dif-
ferences on the outer surface that affect kinesin-1, rather
than the acetylation itself directly regulating the kinesin-1
activity. Consistent with this possibility, acetylation of
mammalian brain microtubules has no effect on kinesin-1
in vitro motility (13,14). By contrast, our results with outer
arm axonemal dynein and brain microtubules show a clear,
strong effect of in vitro acetylation on motility. Although our
results are consistent with inside-out signaling, a potential
caveat is that aTAT may acetylate lysines located on the
outer surface of the microtubule (4,45), which in turn regu-
late outer arm axonemal dynein motility. However, aTAT is
thought to be specific for K40 (10). Thus, it is likely that
acetylation of K40 can be sensed by outer arm axonemal
dynein.
We favor a model in which acetylation of K40 leads to
an allosteric conformational change across the microtu-
bule wall to the site where axonemal dynein binds, some
5.5 nm away (46). Although no such conformational
change was detected in a recent EM study comparing acet-
ylated and deacetylated microtubules (47), the resolution
(~8.5 A˚) may not have been sufficient to detect an allo-
steric effect. An alternative to the allosteric model is
that axonemal dynein residues reach through the microtu-
bule fenestrations to interact directly with K40 (48). How-
ever, this is unlikely given that axonemal dynein’s
microtubule-binding domain binds to the microtubule at
the intradimer a-tubulin-b-tubulin interface whereas K40
is located below the interdimer a-tubulin-b-tubulin inter-
face (46,48).Microtubule acetylation decreases the bound
time of axonemal dynein
To elucidate the mechanism by which K40 acetylation reg-
ulates axonemal dynein, we mathematically modeled the
gliding-assay results using a two-state model (29) for the
axonemal dynein motors. The two-state model assumes
that an axonemal dynein molecule moves a microtubule
through the power stroke distance, d, in the time it is bound,
tbound, to the microtubule. The model assumes that axonemal
dynein has no effect on the microtubule in the time it is un-
bound, tunbound. Axonemal dynein transitions from the
bound to unbound state with a dissociation rate, koff ¼ 1/
tbound, and from the unbound to the bound state with an as-
sociation rate, kon ¼ 1/tunbound. This model is quite different
from that used to describe processive motors such as kine-
sin-1 and cytoplasmic dynein, which take many steps while
bound to the filament (49): in this case the binding to and
unbinding from the filament can be separated from the step-
ping mechanism. Outer arm axonemal dynein spends only aBiophysical Journal 107(12) 2872–2880small fraction of its time in the bound state (40); therefore,
the following duty ratio is small:
r ¼ tbound
tbound þ tunbound: (2)
In gliding assays, if the motor density on the surface (r) or
the microtubule length (L) is great enough so that many mo-
tors are under the microtubule (N¼ rL, [1-r]N<<1), then, at
any one time, there will be at least one axonemal dynein in
the bound state and hence the microtubule gliding speed (v)
will be equal to the power stroke speed, v0, where
v0 ¼ d
tbound
: (3)
Thus, the higher speed of long acetylated microtubules
(vmax) suggests that acetylation either increases the power
stroke distance or decreases the bound time (Eq. 3) of
axonemal dynein. The power stroke distance is likely to
be a property of axonemal dynein alone (independent of
the axonemal dynein-microtubule interaction) given that
the current mechanical model of axonemal dynein’s power
stroke mechanism predicts that step size is determined by
axonemal dynein tail-AAAþ ring linker rearrangements
and AAAþ ring rotations (50). Therefore, we propose that
acetylation decreases the bound time, tbound, i.e., it increases
(by about threefold) the dissociation rate of axonemal
dynein from the microtubule, koff.The CTT has a modest effect on outer arm
axonemal dynein motility
We found that removal of the CTT, and therefore removal of
the associated PTMs, leads to a modest increase in the speed
of outer arm axonemal dynein. Therefore, using the same
reasoning as for acetylation, CTTs decrease axonemal
dynein’s koff, although to a lesser magnitude than acetyla-
tion’s effect. This subtle in vitro effect is in general
agreement with in vivo studies, even though CTT-related
PTMs tend to have a more pronounced effect on motility
(24,25,27,28) than acetylation does (20,22). The reason
for the agreement is that CTT-related PTMs, particularly
polyglutamylation, have a stronger effect on inner arm
axonemal dynein than outer arm axonemal dynein motility
(24–26). Additionally, CTT-related PTMs have competing
effects on the motility of cytoplasmic motors, e.g., detyro-
sination inhibits kinesin-2 whereas polyglutamylation
increases its motility (15). Moreover, the sign of the impact
on gliding velocity, vmax, is consistent with previous
studies showing that polyglutamylation tends to inhibit
axonemal dynein sliding motility (24,26). Finally, our
results show that outer arm axonemal dynein and cyto-
plasmic dynein, which is not affected by changing tubulin
CTTs (15), are differently regulated by the tubulin in
microtubules.
The Tubulin Code Regulates Dynein 2879There are multiple mechanisms by which CTTs might
decrease axonemal dynein speed. Because CTTs are located
on the outer surface of microtubules (43) and can be quite
large, particularly if they are heavily modified with polymo-
difications (2), they may directly interact with or even steri-
cally hinder axonemal dynein. Additionally, because they
are glutamic acid rich and thus negatively charged, CTTs
might electrostatically interact with the positively charged
microtubule-binding domains of axonemal dynein (26).
A simple potential mechanism is that the CTT facilitates
axonemal dynein-microtubule binding by decreasing the
off-rate, leading to a lower speed.Acetylation and CTTs do not have a significant
effect on the duty ratio of axonemal dynein
At intermediate microtubule lengths, we expect the gliding
velocity to depend on length (29,40) as in the following:
v ¼ v0

1 ð1 rÞrLyvmax L
L0 þ L; (4)
where
L0y
lnð2Þ
rr
; (5)
for small r (29). According to Eq. 5, the lack of statistical sig-
nificance of the change in L0 indicates that the duty ratio, r, of
axonemal dynein is unaffected by both K40 acetylation and
CTTs. Therefore, in light of Eq. 2, the finding that r is un-
changed implies that acetylation increases kon threefold and
CTTs decrease kon 35% (because koff was increased threefold
by acetylation and decreased 35%byCTTs). However, the ef-
fects of acetylation and CTTs on L0 have a large uncertainty.
The 95% confidence interval for the slope of the linear fit to
Fig. 1 H was -0.002 to 0.014 mm/min. At the upper end of
the interval, the change in L0 predicts r could have been
reduced by as much as twofold by acetylation; in this case,
acetylation could have increased kon as little as 1.5-fold.
Thus, we estimate that acetylation increases kon somewhere
between 1.5-fold and threefold.More detailed structural, bio-
physical, and biochemical experiments will be necessary to
reveal the mechanism by which it does this.CONCLUSIONS
This study provides direct in vitro evidence of acetylation
and CTTs regulating the motility of axonemal dynein. It
suggests that cells can modify the tubulin to tune it specif-
ically for optimal use in cilia. This model for motor protein
regulation has implications beyond ciliary motility, and it
further strengthens the argument that PTMs of tubulin
help specify the tubulin code by differentially regulating
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